MARBAN EDUARDO has a total of 11 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are KAEMMERER WILLIAM F, PROMETHERA BIOSCIENCES S A /N V and INNOVACELL BIOTECHNOLOGIE AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Syringes | |
#5 | Analysing materials | |
#6 | Diagnosis and surgery | |
#7 | Electrotherapy | |
#8 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Marban Eduardo | 11 |
#2 | Van Eyk Jennifer E | 1 |
#3 | Xue Tian | 1 |
#4 | Li Ronald A | 1 |
#5 | Tsang Suk-Ying | 1 |
#6 | Li Tao-Sheng | 1 |
#7 | Li Ronald | 1 |
#8 | Cheng Ke | 1 |
#9 | Cho Hee Cheol | 1 |
Publication | Filing date | Title |
---|---|---|
US2012315252A1 | Methods of Reducing Teratoma Formation During Allogeneic Stem Cell Therapy | |
US2011300112A1 | Methods for enhancing yield of stem cell cultures and enhancing stem cell therapy | |
US2011256105A1 | Cardiac stem cell and myocyte secreted paracrine factors |